U.S. Markets closed

Imagin Medical Inc. (IMEXF)

Other OTC - Other OTC Delayed Price. Currency in USD
0.19300.0000 (0.00%)
At close: 02:25PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.1930
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.1930 - 0.1930
52 Week Range0.0700 - 0.4400
Avg. Volume3,304
Market Cap2.261M
Beta (5Y Monthly)1.58
PE Ratio (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • PR Newswire

    Ponce Therapeutics Executes Worldwide Exclusive License to Speratum Biopharma's Nano-in™ and No-Pass Mimic™ Nanoparticle Technologies in Anti-Aging and Other Products Initially for Skin

    Ponce Therapeutics, Inc., a company leveraging the growing scientific knowledge surrounding the aging process to develop anti-aging technologies, announced today that it had executed a worldwide, exclusive license to Speratum's proprietary Nano-in™ and No-Pass Mimic™ technologies to advance its lead product, ReBeaut™, a state-of-the-art biotechnology platform to restore the youthful balance of aged or "senescent" and young, vital cells in the skin, targeting the senescent cells for elimination,

  • PR Newswire

    Imagin Medical Announces Stock Option Grants

    Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) ("Imagin" or the "Company") today announced today that, pursuant to the Company's Stock Option Plan, an aggregate of 472,187 shares have been granted to certain employees, board members and consultants as incentive stock options at an exercise price of $0.28 USD per share. The options are exercisable for a period of five years, ending on April 22, 2027.